Next Biometrics Group ASA
OSE:NEXT
Next Biometrics Group ASA
OSE:NEXT
Price:
1.025
NOK
-5.09%
Market Closed
Market Cap:
kr122.9m
Balance Sheet
Balance Sheet Decomposition
Next Biometrics Group ASA
Next Biometrics Group ASA
Balance Sheet Decomposition is not available for
Next Biometrics Group ASA
Next Biometrics Group ASA
Balance Sheet
Next Biometrics Group ASA
Next Biometrics Group ASA
Currency: NOK
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
1
|
70
|
129
|
130
|
106
|
80
|
46
|
89
|
68
|
103
|
69
|
68
|
63
|
|
| Cash Equivalents |
1
|
70
|
129
|
130
|
106
|
80
|
46
|
89
|
68
|
103
|
69
|
68
|
63
|
|
| Total Receivables |
2
|
2
|
23
|
15
|
23
|
33
|
28
|
15
|
4
|
12
|
13
|
17
|
61
|
|
| Accounts Receivables |
0
|
0
|
4
|
2
|
13
|
17
|
13
|
3
|
4
|
12
|
6
|
12
|
57
|
|
| Other Receivables |
2
|
2
|
20
|
13
|
9
|
16
|
15
|
12
|
0
|
0
|
6
|
5
|
4
|
|
| Inventory |
0
|
0
|
17
|
22
|
23
|
28
|
29
|
26
|
22
|
19
|
23
|
23
|
18
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
14
|
3
|
0
|
0
|
14
|
8
|
2
|
3
|
10
|
|
| Total Current Assets |
3
|
72
|
170
|
167
|
166
|
144
|
104
|
130
|
108
|
141
|
107
|
111
|
144
|
|
| PP&E Net |
0
|
0
|
2
|
19
|
16
|
30
|
27
|
31
|
17
|
16
|
12
|
7
|
7
|
|
| PP&E Gross |
0
|
0
|
2
|
19
|
16
|
30
|
27
|
31
|
17
|
16
|
12
|
7
|
7
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
3
|
7
|
22
|
26
|
32
|
47
|
30
|
29
|
34
|
37
|
|
| Intangible Assets |
8
|
8
|
7
|
7
|
19
|
21
|
19
|
12
|
5
|
4
|
3
|
2
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Assets |
10
N/A
|
80
+666%
|
179
+125%
|
193
+8%
|
201
+5%
|
195
-3%
|
150
-23%
|
173
+15%
|
131
-24%
|
162
+23%
|
122
-25%
|
119
-2%
|
152
+28%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
1
|
1
|
5
|
8
|
14
|
22
|
19
|
12
|
11
|
7
|
8
|
6
|
11
|
|
| Accrued Liabilities |
3
|
8
|
8
|
9
|
5
|
3
|
4
|
8
|
4
|
7
|
3
|
8
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
3
|
2
|
2
|
2
|
|
| Other Current Liabilities |
2
|
1
|
5
|
3
|
5
|
6
|
8
|
10
|
8
|
9
|
12
|
9
|
13
|
|
| Total Current Liabilities |
6
|
9
|
10
|
20
|
24
|
30
|
31
|
35
|
27
|
25
|
25
|
24
|
31
|
|
| Long-Term Debt |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
6
|
0
|
1
|
0
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
8
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
|
| Total Liabilities |
15
N/A
|
17
+8%
|
17
+4%
|
20
+16%
|
24
+21%
|
30
+24%
|
31
+2%
|
38
+24%
|
34
-10%
|
27
-20%
|
26
-6%
|
25
-5%
|
34
+37%
|
|
| Equity | ||||||||||||||
| Common Stock |
7
|
9
|
11
|
13
|
15
|
16
|
19
|
43
|
76
|
92
|
92
|
104
|
115
|
|
| Retained Earnings |
33
|
62
|
134
|
239
|
393
|
539
|
369
|
39
|
35
|
5
|
0
|
41
|
67
|
|
| Additional Paid In Capital |
14
|
104
|
268
|
378
|
555
|
688
|
469
|
53
|
57
|
47
|
4
|
31
|
70
|
|
| Other Equity |
7
|
12
|
17
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
63
N/A
|
162
+156%
|
173
+7%
|
177
+3%
|
165
-7%
|
119
-28%
|
135
+13%
|
97
-28%
|
134
+38%
|
96
-28%
|
94
-2%
|
119
+26%
|
|
| Total Liabilities & Equity |
10
N/A
|
80
+666%
|
179
+125%
|
193
+8%
|
201
+5%
|
195
-3%
|
150
-23%
|
173
+15%
|
131
-24%
|
162
+23%
|
122
-25%
|
119
-2%
|
152
+28%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
8
|
10
|
12
|
15
|
17
|
19
|
22
|
45
|
76
|
76
|
92
|
104
|
115
|
|
Switch to:
Switch to:
See Also
Discover More
